# Norman Wolmark
**Type:** Researchers
**Canonical URL:** https://scholariq.org/researchers/norman-wolmark/
## Facts
| Field | Value |
| --- | --- |
| Citations | 123,391 |
| Field | Breast Cancer Treatment Studies |
| h-index | 144 |
| i10-index | 427 |
| Last Known Institution | University of Pittsburgh |
| OpenAlex ID | https://openalex.org/A5055013606 |
| ORCID iD | 0000-0001-7156-1110 |
| Works | 862 |
## Researcher papers
Showing 12 of 15.
- [A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer](https://scholariq.org/papers/a-multigene-assay-to-predict-recurrence-of-tamoxifen-treated-node-negative/)
- [Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer](https://scholariq.org/papers/twenty-year-follow-up-of-a-randomized-trial-comparing-total-mastectomy/)
- [Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study](https://scholariq.org/papers/tamoxifen-for-prevention-of-breast-cancer-report-of-the-national-surgical/)
- [Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer](https://scholariq.org/papers/trastuzumab-plus-adjuvant-chemotherapy-for-operable-her2-positive-breast-cancer/)
- [Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis](https://scholariq.org/papers/pathological-complete-response-and-long-term-clinical-benefit-in-breast-cancer/)
- [Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer](https://scholariq.org/papers/trastuzumab-emtansine-for-residual-invasive-her2-positive-breast-cancer/)
- [Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer](https://scholariq.org/papers/gene-expression-and-benefit-of-chemotherapy-in-women-with-node-negative-estrogen/)
- [Five-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Segmental Mastectomy with or without Radiation in the Treatment of Breast Cancer](https://scholariq.org/papers/five-year-results-of-a-randomized-clinical-trial-comparing-total-mastectomy-and/)
- [Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.](https://scholariq.org/papers/effect-of-preoperative-chemotherapy-on-the-outcome-of-women-with-operable-breast/)
- [Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.](https://scholariq.org/papers/polychemotherapy-for-early-breast-cancer-an-overview-of-the-randomised-trials/)
- [Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial](https://scholariq.org/papers/sentinel-lymph-node-resection-compared-with-conventional-axillary-lymph-node/)
- [Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer](https://scholariq.org/papers/adjuvant-olaparib-for-patients-with-i-brca1-i-or-i-brca2-i-mutated-breast-cancer/)
## Researcher topics
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
## Researcher university
- [University of Pittsburgh](https://scholariq.org/institutions/university-of-pittsburgh/)
---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.